CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
Kimihiko Kaneko(Tohoku University), Masashi Aoki(Tohoku University), Yuji Hashimoto(Chiba Kaihin Municipal Hospital), Ryo Ogawa(Fukushima Medical University), Dagoberto Callegaro(Universidade de São Paulo), Shuhei Nishiyama(Fukushima Medical University), Toshiyuki Takahashi(Fukushima Medical University), Satoru Tanaka(Japan Agency for Marine-Earth Science and Technology), Ichiro Nakashima(Tohoku Medical and Pharmaceutical University), Lawrence Steinman(Stanford University), Kazuo Fujihara(Tohoku University), Hiroshi Kuroda(Fukushima Medical University), Douglas Kazutoshi Sato(Instituto do Cérebro), Yoshiki Takai(Fukushima Medical University), Tetsuya Akaishi(Tohoku University Hospital), Kyoichi Nomura(Saitama Medical University), Tatsuro Misu(Tohoku University)
Cited by 199
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
|Neurology|2015|4.6k
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740